Who invested in PetaGene

2 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$2.1Mraised across 2 rounds since 2018, from 2 sources

Latest round: VentureMay 2023
Biggest round: $2.1MRound · Dec 2018
Investors: 2

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20192020202120222023

$2.1MRound?Venture

First round: Round, $2.1M
Biggest round: $2.1M
Between rounds: 4.3 years

The rounds

May 2023
VentureAmount undisclosed1 new
- Entrepreneur First
Source recorded
Dec 2018
Round$2.1M1 new
- Romulus Capital
Reported by TechCrunch

Founders and team

From PetaGene's own website: 3 on the team.

Dr Christophe TrefoisHead of Facility, Clinical Genomics Gothenburg
Per SikoraHead of Facility, Clinical Genomics Gothenburg
Allison ProffittBoston, USA Editorial Director of Bio-IT World

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Round2018Venture2023

Entrepreneur First

Romulus Capital

Everyone who backed them

Entrepreneur FirstAccelerator1round

Romulus CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list PetaGene as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.